Medicare Enrolled

Dr. Samer Shihabi, M.D.

Hematology · Sacramento, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
3301 C ST, Sacramento, CA 95816
9167335300
In practice since 2006 (19 years)
NPI: 1730110768 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shihabi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shihabi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shihabi

Dr. Samer Shihabi is a hematology specialist in Sacramento, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shihabi performed 12,822 Medicare services across 1,335 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shihabi received a total of $4,458 from 13 pharmaceutical and/or device companies across 22 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shihabi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in CA $4,458 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,822
Medicare services
Top 11% in CA for hematology
1,335
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~675 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,900 $18 $86
Epoetin alfa injection (Retacrit) for anemia
An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units.
2,760 $6 $42
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,562 $0 $5
Anti-nausea injection (ondansetron/Zofran) 744 $0 $22
Anti-nausea injection (Aloxi/palonosetron) 680 $1 $111
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
482 $105 $515
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
459 $67 $359
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
296 $14 $98
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
282 $6 $169
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
264 $116 $788
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
206 $12 $86
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
179 $25 $141
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
146 $56 $305
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
125 $143 $708
Blood sample collection from implanted device
This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body.
111 $24 $113
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
110 $57 $311
New patient office visit, complex (60-74 min) 99 $177 $965
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
97 $25 $189
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
91 $1 $6
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
69 $8 $12
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $124 $765
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
45 $21 $128
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
34 $28 $209
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
16 $144 $921
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $77 $503
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.5% high complexity
83.2% medium
11.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,458
Total received (2018-2024)
Avg $637/year across 7 years
Top 50% in CA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
13
Companies
22
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,688 (82.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$525 (11.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$246 (5.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$44
2023
$1,181
2022
$435
2021
$60
2020
$2,322
2019
$203
2018
$213

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
US Oncology Corporate, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,438
COMSORT, Inc
$250
Novocure GmbH
$200
Alexion Pharmaceuticals, Inc.
$200
McKesson Specialty Care Distribution, LLC
$111
E.R. Squibb & Sons, L.L.C.
$58
US Oncology Corporate, Inc.
$47
PFIZER INC.
$45
Lilly USA, LLC
$30
Janssen Biotech, Inc.
$24
Hologic, LLC
$22
EISAI INC.
$22
Gilead Sciences, Inc.
$12
Top 3 companies account for 87.2% of all-time payments
Associated products mentioned in payments ›
Aptima HPV · Erleada · IBRANCE · IMFINZI · KEYTRUDA · Lenvima · OPDIVO · TAGRISSO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a hematology specialist in Sacramento?
Compare hematologists in the Sacramento area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
9
Per 100K population
0.6
County median income
$88,724
Nearest hospital
SUTTER MEDICAL CENTER, SACRAMENTO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shihabi is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with consulting-driven industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shihabi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Shihabi performed 3,900 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shihabi receive payments from pharmaceutical companies?
Yes. Dr. Shihabi received a total of $4,458 from 13 companies across 22 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shihabi's costs compare to other hematologists in Sacramento?
Dr. Shihabi's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shihabi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →